Apollo Medical Holdings Inc (ASTH) Peer Comparison
$36.72
As on 26-Apr-2024 09:30EDT
Market cap
$-- Mln
Revenue (TTM)
$1,387 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
| Apollo Medical Holdings Inc (ASTH) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
-- | 11,819 | 10,012 | 6,633 | 6,836 |
Revenue ($ Mln) |
1,387 | 6,206 | 5,487 | 2,595 | 2,578 |
Net Profit ($ Mln) |
60.72 | 621.00 | 378.70 | 274.99 | -142.03 |
Net Margin (%) |
4.38 | 10.01 | 6.90 | 10.60 | -5.51 |
RoE (%) |
10.50 | 16.23 | 16.18 | 30.39 | -32.84 |
Price to Earnings |
-- | 20.00 | 26.92 | 25.55 | -- |
Price-To-Book |
-- | 4.64 | 4.18 | 7.84 | 20.44 |
Income Statement ($ Mln)
| Apollo Medical Holdings Inc (ASTH) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1,386.66 | 4,801.20 | 3,729.36 | 2,264.42 | 872.00 |
|
Cost of Revenue
|
1,171.70 | 2,818.40 | 3,138.60 | 1,465.60 | 157.05 |
|
Gross Profit
|
214.96 | 1,982.80 | 590.76 | 798.82 | 714.95 |
|
Operating Expenses
|
1,302.05 | 258.00 | 335.39 | 458.25 | 744.40 |
|
Operating Profit (EBIT)
|
84.61 | 1,724.80 | 255.37 | 340.57 | -29.45 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
89.84 | 607.20 | 272.76 | 350.37 | -21.57 |
|
Provision for Tax
|
-- | 132.20 | 62.91 | 77.86 | 1.98 |
|
Profit after Tax (Net Income)
|
60.72 | 352.00 | 209.40 | 272.51 | -23.55 |
|
Minority Interest
|
-- | 649.70 | 5.45 | -- | -- |
|
Consolidated Profit
|
-- | 349.60 | -- | 272.51 | -- |
Liabilities ($ Mln)
| Apollo Medical Holdings Inc (ASTH) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
614.22 | 1,647.50 | 1,491.87 | 1,107.88 | 344.03 |
|
Minority Interest
|
-- | 649.70 | 5.45 | -- | -- |
|
Non-Current Liabilities
|
303.92 | 3,148.80 | 1,945.48 | 248.17 | 8.69 |
|
Current Liabilities
|
218.67 | 656.40 | 734.75 | 312.05 | 88.47 |
|
Total Liabilities
|
933.36 | 6,102.40 | 4,177.54 | 1,668.10 | 441.19 |
Assets ($ Mln)
| Apollo Medical Holdings Inc (ASTH) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
471.85 | 5,260.60 | 3,130.61 | 1,167.25 | 176.13 |
|
Current Assets
|
461.51 | 841.80 | 1,046.93 | 500.84 | 265.05 |
|
Total Assets
|
-- | 6,102.40 | 4,177.54 | 1,668.10 | 441.19 |
|
Total Debt*
|
-- | 2,932.80 | 1,871.30 | 155.11 | 9.95 |
|
Net Current Assets
|
242.83 | 185.40 | 312.18 | 188.79 | 176.59 |
Cashflow ($ Mln)
| Apollo Medical Holdings Inc (ASTH) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
68.23 | 850.80 | 376.67 | 330.30 | 73.48 |
|
Cash Flow from Investing Activities
|
-- | -602.80 | -182.70 | -60.64 | -12.11 |
|
Cash from Financing Activities
|
3.42 | -197.20 | -0.61 | -79.83 | -11.48 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Apollo Medical Holdings Inc (ASTH) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
8.76 | 7.93 | 6.77 | 23.61 | -7.02 |
|
ROE (%)
|
10.50 | 23.80 | 15.29 | 28.59 | -7.18 |
|
ROA (%)
|
6.39 | 6.00 | 5.49 | 17.52 | -5.83 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
4.38 | 7.33 | 5.61 | 12.03 | -2.70 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Apollo Medical Holdings Inc (ASTH) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.21 | 0.10 | 0.23 | 0.06 | 0.65 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
34.42 | 29.89 | -6.80 | 9.17 | 64.15 |
|
EPS Growth (%)
|
0.24 | 0.29 | -0.10 | 0.08 | 0.65 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Apollo Medical Holdings Inc (ASTH) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
29.55 | 19.24 | 30.84 | 32.77 | -79.28 |
|
Price / Book Value
|
2.92 | 4.11 | 4.33 | 8.06 | 5.43 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-- | 9.51 | 22.09 | 21.29 | -137.33 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Apollo Medical Holdings Inc (ASTH) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-- | 1.78 | 1.25 | 0.14 | 0.03 |
|
Short term debt to equity ratio
|
-- | 0.03 | 0.06 | 0.05 | 0.00 |
|
Current Ratio
|
2.11 | 1.28 | 1.42 | 1.61 | 3.00 |
|
Quick Ratio
|
-- | 1.17 | -- | 1.57 | 2.74 |
|
Interest Coverage
|
-- | 5.10 | 34.73 | 113.73 | -- |
Operating Efficiency Ratios
| Apollo Medical Holdings Inc (ASTH) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Chemed Corp (CHE) | Hims Hers Health Inc (HIMS) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
9.79 | 12.74 | 13.01 | 8.02 | 0.77 |
|
Asset Turnover
|
1.46 | 0.82 | 0.98 | 1.46 | 2.16 |
|
Receivable days
|
33.65 | 43.68 | 43.75 | 25.88 | 2.09 |
|
Inventory Days
|
-- | 6.76 | 0.54 | 2.78 | 51.20 |
|
Payable days
|
4.30 | 19.63 | 9.89 | 13.20 | 87.72 |
|
Cash Conversion Cycle
|
-- | 30.81 | 34.41 | 15.46 | -34.43 |